title: Efficacy of an injection of dinoprost tromethamine when given subcutaneously on luteal regression in lactating Holstein cows.
abstract: The objectives of these studies were to evaluate the efficacy of a PGF(2alpha) (PGF) analog given through different routes on causing luteal regression in lactating dairy cows. In Experiment 1, lactating Holstein cows (n=118) at random stages of lactation were blocked by parity and days in milk (DIM) and, within each block, randomly assigned to receive PGF as an intra-muscular (IM) injection in the semimembranous/semitendinous muscle (CON), subcutaneous (SC) injection in the cervical area (SCN), or SC injection in the ischio-rectal fossa (IRF). Blood was sampled at 0, 12, 24, 36, and 48 h after treatment for assessment of progesterone concentration. In Experiment 2, a total of 379 lactating Holstein cows, 46+/-7 DIM, were blocked by DIM and, within each block, randomly assigned to receive treatment similar to CON or IRF groups from Experiment 1. Blood was sampled 0 and 48 h after treatment for assessment of progesterone concentration. Cows were classified as experiencing luteal regression when progesterone concentration was <1.0 ng/mL or <40% of initial concentration (0 h=100%). In Experiment 1, there was no effect of route of PGF treatment on decline in progesterone concentration and on the proportion of cows experiencing luteal regression by 12, 24, 36, and 48 h after treatment. Similarly, in Experiment 2, route of treatment did not affect either the decline in progesterone concentration or the proportion of cows that had luteal regression by 48 h after treatment. Treatment of lactating dairy cows with 25mg of PGF given SC in the ischio-rectal fossa did not affect either the decline in progesterone concentration or the proportion of cows that experienced luteal regression by 12, 24, 36, and 48 h after PGF treatment.
authors.affiliation: Caine Veterinary Teaching Center, University of Idaho, 1020 E. Homedale Road, Caldwell, ID 83607, United States. rchebel@uidaho.edu
authors.forename: Ricardo C
authors.initials: RC
authors.lastname: Chebel
authors.forename: José E P
authors.initials: JE
authors.lastname: Santos
authors.forename: Heloísa M
authors.initials: HM
authors.lastname: Rutigliano
authors.forename: Ronaldo L A
authors.initials: RL
authors.lastname: Cerri
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002417:Cattle; D003612:Dairying; D015237:Dinoprost / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D005260:Female; D007273:Injections, Intramuscular / Q000662:veterinary; D007279:Injections, Subcutaneous / Q000662:veterinary; D007774:Lactation / Q000502:physiology; D003341:Luteolysis / Q000187:drug effects*; D016017:Odds Ratio; D011374:Progesterone / Q000097:blood; D013997:Time Factors
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D011374:Progesterone; D015237:Dinoprost; C010714:dinoprost tromethamine